Matthew Wosnitzer, M.D. is a urologic surgeon and physician scientist specializing in male infertility, microsurgical reconstruction, varicocele, erectile dysfunction, and low testosterone issues in Fairfield, Connecticut. Dr. Wosnitzer completed his undergraduate studies at Columbia University (magna cum laude with Biology major and Philosophy concentration) in 2001. He completed medical school at Robert Wood Johnson Medical School in New Jersey, where he graduated with highest honors (Alpha Omega Alpha) in 2006. During medical school, Dr. Wosnitzer was selected for a Doris Duke Clinical Research Fellowship at Mount Sinai School of Medicine studying HIV-associated Nephropathy (HIVAN). Dr. Wosnitzer completed urology residency in the Department of Urology at Columbia University Medical Center/New York Presbyterian Hospital in New York City and is currently an Instructor and Male Reproductive Medicine Fellow in the Department of Urology, at Weill Cornell Medical College/ New York Presbyterian Hospital. Dr. Wosnitzer has been awarded the New York Academy of Medicine/Ferdinand C. Valentine Research Fellowship in Urology for 2013-2014. Dr. Wosnitzer has also been selected by the NIH-Eunice Kennedy Shriver National Institute of Child and Human Development (NICHD) as a Clinical Research/Reproductive Scientist Training (CREST) Scholar Awardee for 2013-2014.
Dr. Wosnitzer has published many peer-reviewed publications and chapters in male infertility, andrology, and general urology, received numerous awards for his work, and presents consistently throughout the United States including the annual meetings of the American Urological Association and American Society of Reproductive Medicine. Dr. Wosnitzer’s research interests include causes of male infertility, study of microsurgical techniques for vasectomy reversal, and antibiotic usage patterns for inflatable penile prosthesis insertion. Dr. Wosnitzer also has conducted clinical and basic science research to study intravesical treatment of BCG-refractory non-muscle invasive bladder cancer (docetaxel/nanoparticle albumin-bound paclitaxel), and systemic platinum-based chemotherapy for advanced bladder cancer. Dr. Wosnitzer is involved in the peer-review process as a reviewer for the Scandinavian Journal of Urology. He has been recognized as a 2013 Top Urologist in Manhattan and New York State by HealthTap.com and was named a 2013-2014 Doximity.com Physician Fellow. Dr. Wosnitzer is married and enjoys tennis, jogging, and anything technological in his free time.
Selected Peer-reviewed Publications:
Follow Dr. Wosnitzer: